Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 658 | 501 | 734 | 645 | 654 |
| Cost of Goods | 457 | 577 | 678 | 760 | 781 |
| Gross Profit | 201 | -76 | 56 | -115 | -127 |
| Operating Expenses | 3,615 | 3,629 | 3,224 | 3,257 | 2,910 |
| Operating Income | -2,957 | -3,128 | -2,490 | -2,612 | -2,256 |
| Interest Expense | 23 | 24 | 72 | 22 | 2 |
| Pre-tax Income | -2,980 | -3,152 | -2,562 | -2,634 | -2,258 |
| Net Income Continuous | -2,980 | -3,152 | -2,562 | -2,634 | -2,258 |
| Net Income | $-2,980 | $-3,152 | $-2,562 | $-2,634 | $-2,802 |
| EPS Basic Total Ops | -52.16 | -87.66 | -74.18 | -101.15 | 1,159.84 |
| EPS Basic Continuous Ops | -51.73 | -87.20 | -73.96 | -102.20 | 1,161.65 |
| EPS Diluted Total Ops | -52.16 | -87.66 | -74.18 | -101.15 | 1,159.84 |
| EPS Diluted Continuous Ops | -51.73 | -87.20 | -73.96 | -102.20 | 1,161.65 |
| EBITDA(a) | $-2,910 | $-3,081 | $-2,445 | $-2,567 | $-2,218 |